SYNERGISTIC COMPLEMENT LYSIS BY MONOCLONAL-ANTIBODIES TO THE HUMAN-LEUKOCYTE COMMON ANTIGEN REQUIRES BOTH THE CLASSICAL AND ALTERNATIVE PATHWAYS

被引:17
作者
BINDON, CI
HALE, G
HUGHESJONES, N
GORICK, B
WALDMANN, H
机构
[1] UNIV CAMBRIDGE,DEPT PATHOL,DIV IMMUNOL,CAMBRIDGE CB2 1QP,ENGLAND
[2] MRC,RES CTR,MRC MECH TUMOR IMMUN UNIT,CAMBRIDGE CB2 2QH,ENGLAND
关键词
D O I
10.1016/0161-5890(87)90039-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:587 / 594
页数:8
相关论文
共 30 条
[1]   THERAPEUTIC POTENTIAL OF MONOCLONAL-ANTIBODIES TO THE LEUKOCYTE-COMMON ANTIGEN - SYNERGY AND INTERFERENCE IN COMPLEMENT-MEDIATED LYSIS [J].
BINDON, CI ;
HALE, G ;
CLARK, M ;
WALDMANN, H .
TRANSPLANTATION, 1985, 40 (05) :538-544
[3]   MONOCLONAL-ANTIBODY TO A HUMAN LEUKOCYTE-SPECIFIC MEMBRANE GLYCOPROTEIN PROBABLY HOMOLOGOUS TO THE LEUKOCYTE-COMMON (L-C) ANTIGEN OF THE RAT [J].
DALCHAU, R ;
KIRKLEY, J ;
FABRE, JW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1980, 10 (10) :737-744
[4]  
ELLIOTT EV, 1978, IMMUNOLOGY, V34, P405
[5]   PROPERDIN FACTOR D - CHARACTERIZATION OF ITS ACTIVE-SITE AND ISOLATION OF PRECURSOR FORM [J].
FEARON, DT ;
AUSTEN, KF ;
RUDDY, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 139 (02) :355-366
[6]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY DUE TO RESISTANCE OF ZYMOSAN-BOUND AMPLIFICATION CONVERTASE TO ENDOGENOUS REGULATORY MECHANISMS [J].
FEARON, DT ;
AUSTEN, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (04) :1683-1687
[7]  
FOLKERD EJ, 1980, IMMUNOLOGY, V41, P179
[8]   DIFFERENCES IN THE ABILITY OF RAT IGG SUBCLASSES TO CONSUME COMPLEMENT IN HOMOLOGOUS AND HETEROLOGOUS SERUM [J].
FUST, G ;
MEDGYESI, GA ;
BAZIN, H ;
GERGELY, J .
IMMUNOLOGY LETTERS, 1980, 1 (05) :249-253
[9]   RAT-X-RAT HYBRID MYELOMAS AND A MONOCLONAL ANTI-FD PORTION OF MOUSE IGG [J].
GALFRE, G ;
MILSTEIN, C ;
WRIGHT, B .
NATURE, 1979, 277 (5692) :131-133
[10]  
HALE G, 1983, BLOOD, V62, P873